J. Maggs

发表

Drug-protein conjugates--XVI. Studies of sorbinil metabolism: formation of 2-hydroxysorbinil and unstable protein conjugates.

B. K. Park, J. Maggs, 1988, Biochemical pharmacology.

FORMATION AND PROTEIN BINDING OF THE ACYL GLUCURONIDE OF A LEUKOTRIENE B4 ANTAGONIST (SB-209247): RELATION TO SPECIES DIFFERENCES IN HEPATOTOXICITY

B. K. Park, J. Maggs, J. Kenny, 2005, Drug Metabolism and Disposition.

Methapyrilene hepatotoxicity is associated with increased hepatic glutathione, the formation of glucuronide conjugates, and enterohepatic recirculation.

B. K. Park, J. Maggs, B K Park, 2000, Chemico-biological interactions.

Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo.

M. Pirmohamed, W. Rapeport, B. K. Park, 2001, Chemical research in toxicology.

α-Hydroxytamoxifen, a genotoxic metabolite of tamoxifen in the rat: identification and quantification in vivo and in vitro

B. K. Park, J. Maggs, D. Boocock, 1999 .

Convenient syntheses of halo-dibenz[b,f]azepines and carbamazepine analogues via N-arylindoles.

B. K. Park, P. O’Neill, J. Maggs, 2013, Organic & biomolecular chemistry.

Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine.

B. K. Park, P. O’Neill, J. Maggs, 1995, Xenobiotica; the fate of foreign compounds in biological systems.

Activation of Human Dendritic Cells by p-Phenylenediamine

K. L. Mathews, D. Basketter, B. K. Park, 2007, Journal of Pharmacology and Experimental Therapeutics.

The toxicity of amodiaquine and its principal metabolites towards mononuclear leucocytes and granulocyte/monocyte colony forming units.

A. Breckenridge, B. K. Park, J. Maggs, 1990, British journal of clinical pharmacology.

Bioactivation of carbamazepine in the rat in vivo. Evidence for the formation of reactive arene oxide(s).

B. K. Park, J. Maggs, S. Madden, 1996, Drug metabolism and disposition: the biological fate of chemicals.

Direct Evidence for the Formation of Diastereoisomeric Benzylpenicilloyl Haptens from Benzylpenicillin and Benzylpenicillenic Acid in Patients

M. Pirmohamed, B. K. Park, D. Naisbitt, 2011, Journal of Pharmacology and Experimental Therapeutics.

Safety assessment of peroxide antimalarials: clinical and chemical perspectives.

M. Pirmohamed, B. K. Park, P. O’Neill, 1998, British journal of clinical pharmacology.

The metabolism of 16-fluoroestradiols in vivo: Chemical strategies for restricting the oxidative biotransformations of an estrogen-receptor imaging agent

B. K. Park, J. Maggs, T. L. Gilchrist, 1997, Steroids.

The biliary and urinary metabolites of [3H]17α-ethynylestradiol in women

A. Breckenridge, J. Maggs, B. K. Park, 1983 .

Cortisol metabolism by human liver in vitro—I. Metabolite identification and inter-individual variability

B. K. Park, D. Back, J. Maggs, 1992, The Journal of Steroid Biochemistry and Molecular Biology.

Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation.

M. Pirmohamed, B. K. Park, D. Naisbitt, 2002, Molecular pharmacology.

Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes

B. K. Park, S. Powell, G. Edwards, 1998, British journal of pharmacology.

Metabolism-dependent neutrophil cytotoxicity of amodiaquine: A comparison with pyronaridine and related antimalarial drugs.

M. Pirmohamed, B. K. Park, D. Naisbitt, 1998, Chemical research in toxicology.

A comparative study oftheformation ofchemically reactive drugmetabolites byhumanliver microsomes

N. Kitteringham, B. K. Park, J. Maggs, 1988 .

A comparative study of the formation of chemically reactive drug metabolites by human liver microsomes.

N. Kitteringham, B. K. Park, J. Maggs, 1988, British journal of clinical pharmacology.

Drug-protein conjugates--II. An investigation of the irreversible binding and metabolism of 17 alpha-ethinyl estradiol in vivo.

B. K. Park, J. Maggs, P. Grabowski, 1983, Biochemical pharmacology.

Drug-protein conjugates--V. Sex-linked differences in the metabolism and irreversible binding of 17 alpha-ethinylestradiol in the rat.

B. K. Park, J. Maggs, P. Grabowski, 1983, Biochemical pharmacology.

The sexually differentiated metabolism of [6,7-3H]17β-oestradiol in rats: Male-specific 15α- and male-selective 16α-hydroxylation and female-selective catechol formation

J. Maggs, P. Morgan, B. Pak, 1992, The Journal of Steroid Biochemistry and Molecular Biology.

Quantification of urinary mevalonic acid as a biomarker of HMG-CoA reductase activity by a novel translational LC-MS/MS method.

M. Pirmohamed, I. Wilson, M. Coen, 2014, Bioanalysis.

Autoxidative formation of a chemically reactive intermediate from amodiaquine, a myelotoxin and hepatotoxin in man.

A. Breckenridge, N. Kitteringham, B. K. Park, 1987, Biochemical pharmacology.

Immunogenicity of amodiaquine in the rat.

N. Kitteringham, B. K. Park, J. Maggs, 1990, International archives of allergy and applied immunology.

Assessment of the effects of metabolism on the estrogenic activity of xenoestrogens: a two-stage approach coupling human liver microsomes and a yeast estrogenicity assay.

J. Ashby, J. Sumpter, D. Paton, 2001, The Journal of pharmacology and experimental therapeutics.

Obstacles to the prediction of estrogenicity from chemical structure: assay-mediated metabolic transformation and the apparent promiscuous nature of the estrogen receptor.

J. Ashby, P. Lefevre, W. Pennie, 2000, Biochemical pharmacology.

Cortisol metabolism in vitro—II. Species difference

B. K. Park, D. Back, J. Maggs, 1993, The Journal of Steroid Biochemistry and Molecular Biology.

Investigation of the immunogenicity of p-phenylenediamine and Bandrowski's base in the mouse.

B. Kevin Park, D. Naisbitt, J. Maggs, 2009, Toxicology letters.

Nonenzymatic Formation of a Novel Hydroxylated Sulfamethoxazole Derivative in Human Liver Microsomes: Implications for Bioanalysis of Sulfamethoxazole Metabolites

B. K. Park, D. Naisbitt, J. Maggs, 2008, Drug Metabolism and Disposition.

An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.

N. Kitteringham, B. K. Park, J. Maggs, 1988, British journal of clinical pharmacology.

Dexamethasone Metabolism in Species Differences Vitro

B. K. Park, E. Tomlinson, D. Back, 1997 .

Dexamethasone metabolism in vitro: Species differences

B. K. Park, E. Tomlinson, D. Back, 1997, The Journal of Steroid Biochemistry and Molecular Biology.

Catecholestrogens as mediators of carcinogenesis: correlation of aromatic hydroxylation of estradiol and its fluorinated analogs with tumor induction in Syrian hamsters.

B. K. Park, J. Maggs, T. L. Gilchrist, 1994, Molecular pharmacology.

Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway

J. Foreman, J. Maggs, P. Turner, 2000, British journal of pharmacology.

Comparison of the reactivity of antimalarial 1,2,4,5-tetraoxanes with 1,2,4-trioxolanes in the presence of ferrous iron salts, heme, and ferrous iron salts/phosphatidylcholine.

R. Amewu, James Chadwick, S. Ward, 2011, Journal of medicinal chemistry.

Hepatocellular bioactivation and cytotoxicity of the synthetic endoperoxide antimalarial arteflene.

B. Kevin Park, P. O’Neill, G. Edwards, 2004, Chemico-biological interactions.

Metabolism of the antimalarial endoperoxide Ro 42-1611 (arteflene) in the rat: evidence for endoperoxide bioactivation.

B. K. Park, P. O’Neill, J. Maggs, 1999, The Journal of pharmacology and experimental therapeutics.

Synthesis, antimalarial activity, biomimetic iron(II) chemistry, and in vivo metabolism of novel, potent C-10-phenoxy derivatives of dihydroartemisinin.

B. K. Park, S. Ward, P. O’Neill, 2001, Journal of medicinal chemistry.

The Role of Heme and the Mitochondrion in the Chemical and Molecular Mechanisms of Mammalian Cell Death Induced by the Artemisinin Antimalarials*

B. K. Park, P. O’Neill, J. Maggs, 2010, The Journal of Biological Chemistry.

Biomimetic Fe(II)-mediated degradation of arteflene (Ro-42-1611). The first EPR spin-trapping evidence for the previously postulated secondary carbon-centered cyclohexyl radical.

B. K. Park, S. Ward, P. O’Neill, 2000, The Journal of organic chemistry.

Biliary metabolites of beta-artemether in rats: biotransformations of an antimalarial endoperoxide.

B. K. Park, S. Ward, P. O’Neill, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Evidence for the Involvement of Carbon-centered Radicals in the Induction of Apoptotic Cell Death by Artemisinin Compounds*

G. Cohen, B. K. Park, James Chadwick, 2007, Journal of Biological Chemistry.

Measurement of Cortisol Metabolites in Faeces of Ruminants

R. Palme, E. Möstl, J. Maggs, 2002, Veterinary Research Communications.

The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat.

M. Pirmohamed, Research Fellow, N. Kitteringham, 1997, The Journal of pharmacology and experimental therapeutics.

Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for the 21st century.

C. Davis, B. K. Park, Peter D Gibbons, 2009, Journal of medicinal chemistry.

Characterization of Peroxidases Expressed in Human Antigen Presenting Cells and Analysis of the Covalent Binding of Nitroso Sulfamethoxazole to Myeloperoxidase.

B. K. Park, D. Naisbitt, R. Jenkins, 2015, Chemical research in toxicology.

The bioactivation of amodiaquine by human polymorphonuclear leucocytes in vitro: chemical mechanisms and the effects of fluorine substitution.

B. K. Park, P. O’Neill, J. Maggs, 1995, Biochemical pharmacology.

Convenient syntheses of benzo-fluorinated dibenz[b,f]azepines: rearrangements of isatins, acridines, and indoles.

J. Bacsa, P. O’Neill, J. Maggs, 2011, Organic letters.

Ruth H. Hughes, B. K. Park, P. Stocks, 2003, Journal of medicinal chemistry.

Metabolic and chemical origins of cross-reactive immunological reactions to arylamine benzenesulfonamides: T-cell responses to hydroxylamine and nitroso derivatives.

B. K. Park, D. Naisbitt, P. O’Neill, 2010, Chemical research in toxicology.

Acyl glucuronides: the good, the bad and the ugly.

Dominic P. Williams, B. K. Park, J. Maggs, 2010, Biopharmaceutics & drug disposition.

Cyclization of the acyl glucuronide metabolite of a neutral endopeptidase inhibitor to an electrophilic glutarimide: synthesis, reactivity, and mechanistic analysis.

K. Beaumont, B. K. Park, R. Jenkins, 2007, Journal of medicinal chemistry.

Comparison of the metabolism and toxicity of dapsone in rat, mouse and man.

M. Pirmohamed, B. K. Park, J. Maggs, 1997, The Journal of pharmacology and experimental therapeutics.

The role of metabolic activation in drug-induced hepatotoxicity.

Munir Pirmohamed, Dominic P. Williams, M. Pirmohamed, 2005, Annual review of pharmacology and toxicology.

The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazole.

M. Pirmohamed, B. K. Park, J. Maggs, 2003, British journal of clinical pharmacology.

Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases.

M. Pirmohamed, B. Burchell, B. K. Park, 2002, Drug metabolism and disposition: the biological fate of chemicals.

The rat biliary metabolites of dihydroartemisinin, an antimalarial endoperoxide.

B. K. Park, P. O’Neill, J. Maggs, 1997, Drug metabolism and disposition: the biological fate of chemicals.

Efficient preparations of the beta-glucuronides of dihydroartemisinin and structural confirmation of the human glucuronide metabolite.

B. K. Park, P. O’Neill, J. Maggs, 2001, Journal of medicinal chemistry.

Metabolism of lamotrigine to a reactive arene oxide intermediate.

M. Pirmohamed, B. K. Park, D. Naisbitt, 2000, Chemical research in toxicology.

The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man.

Dominic P. Williams, M. Pirmohamed, B. K. Park, 1995, The Journal of pharmacology and experimental therapeutics.

The metabolism of 2,4-dibromo [6,7-3H]17β-oestradiol in the rat: Ring-A dibromination blocks male-specific 15α-hydroxylation and catechol formation

B. K. Park, J. Maggs, P. C. Page, 1992, The Journal of Steroid Biochemistry and Molecular Biology.

Acyl glucuronides: biological activity, chemical reactivity, and chemical synthesis.

John C Lindon, Ian D Wilson, I. Wilson, 2006, Journal of medicinal chemistry.

Identification of the Thiophene Ring of Methapyrilene as a Novel Bioactivation-Dependent Hepatic Toxicophore

Ian D. Wilson, John R. Harding, Dominic P. Williams, 2008, Journal of Pharmacology and Experimental Therapeutics.

Quantifying the Metabolic Activation of Nevirapine in Patients by Integrated Applications of NMR and Mass Spectrometries

Dominic P. Williams, M. Pirmohamed, L. Lian, 2010, Drug Metabolism and Disposition.

Role of reactive metabolites in drug-induced hepatotoxicity.

D A Smith, Dominic P. Williams, D. Smith, 2010, Handbook of experimental pharmacology.

Efficient synthesis of 1β-O-acyl glucuronides via selective acylation of allyl or benzyl d-glucuronate

John R. Harding, B. K. Park, J. Maggs, 2007 .

Syntheses and characterization of the acyl glucuronide and hydroxy metabolites of diclofenac.

B. K. Park, J. Maggs, X. Meng, 2004, Journal of medicinal chemistry.

Drug-protein conjugates--XIV. Mechanisms of formation of protein-arylating intermediates from amodiaquine, a myelotoxin and hepatotoxin in man.

N. Kitteringham, B. K. Park, J. Maggs, 1988, Biochemical pharmacology.

Mass Spectrometric Characterization of Circulating Covalent Protein Adducts Derived from a Drug Acyl Glucuronide Metabolite: Multiple Albumin Adductions in Diclofenac Patients

Dominic P. Williams, J. G. Kenna, G. Aithal, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Mass Spectrometric Characterization of Circulating Covalent Protein Adducts Derived from a Drug Acyl Glucuronide Metabolite: Multiple Albumin Adductions in Diclofenac Patients

Dominic P. Williams, J. G. Kenna, G. Aithal, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Current Status and Recent Advances in the Chromatography and Mass Spectrometry of Ecdysteroids

R. Evershed, M. Prescott, H. Rees, 1990 .

The effect of 2,2'-substitution on the metabolism and toxicity of dapsone in vitro and in vivo.

B. K. Park, S. Ward, M. Coleman, 1998, Environmental toxicology and pharmacology.

2-Hydroxylation of ethinyloestradiol in relation to the oxidation of sparteine and antipyrine.

B. K. Park, D. Back, J. Maggs, 1984, British journal of clinical pharmacology.

The biotransformation of 17 alpha-ethynyl[3H]estradiol in the rat: irreversible binding and biliary metabolites.

B. K. Park, J. Maggs, P. Grabowski, 1982, Xenobiotica; the fate of foreign compounds in biological systems.

Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation.

B. K. Park, E. Tomlinson, D. Back, 1996, The Journal of pharmacology and experimental therapeutics.

Structure-metabolism relationships of ring-A halogenated analogues of 17α-ethynyloestradiol

B. K. Park, J. Maggs, N. M. Bonham, 1994, The Journal of Steroid Biochemistry and Molecular Biology.

Protection of catechol oestrogen from oxidation during enzymic hydrolysis of biliary conjugates.

B. K. Park, J. Maggs, P. Grabowski, 1983, Journal of steroid biochemistry.

Regioselective synthesis of a-ring halogenated derivatives of 17α-ethynyloestradiol

B. K. Park, J. Maggs, P. C. Page, 1991 .

Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis.

M Pirmohamed, Dominic P. Williams, M. Pirmohamed, 1997, The Journal of pharmacology and experimental therapeutics.

The metabolism of 2,4-dibromo-17α-ethynyl[6,7-3H]oestradiol in the rat

B. K. Park, J. Maggs, F. Hussain, 1990 .

The metabolism of 2- and 4-fluoro-17 beta-oestradiol in the rat and its implications for oestrogen carcinogenesis.

B. K. Park, J. Maggs, P. Morgan, 1992, Biochemical pharmacology.

Metabolism in the rat of potassium DL-octan-2-sulphate, a secondary alkyl sulphate.

D. Howes, J. Maggs, K. S. Dodgson, 1982, Xenobiotica; the fate of foreign compounds in biological systems.

Octan-2-sulphate degradation in the isolated perfused rat liver.

J. Maggs, C. Curtis, A. H. Olavesen, 1984, Biochemical pharmacology.

The effect of configuration of the sulphate moiety on the metabolism of potassium octan-2-sulphate in the rat.

D. Howes, J. Maggs, K. S. Dodgson, 1982, Xenobiotica; the fate of foreign compounds in biological systems.

Synthesis of DL‐[2‐14C]octan‐2‐sulphate and [35S]‐labelled D(+)‐and L(−)‐octan‐2‐sulphate

J. Maggs, C. T. James, A. H. Olavesen, 1980 .

Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine

M. Pirmohamed, A. Marson, B. K. Park, 2020, British journal of clinical pharmacology.

Mass Spectrometric Characterization of Circulating Covalent Protein Adducts Derived from Epoxide Metabolites of Carbamazepine in Patients.

M. Pirmohamed, A. Marson, B. K. Park, 2017, Chemical research in toxicology.

Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography/mass spectrometry.

M. Pirmohamed, N. Kitteringham, B. K. Park, 1997, Drug metabolism and disposition: the biological fate of chemicals.

The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites.

B. K. Park, D. Back, J. Maggs, 1987, British journal of clinical pharmacology.

Bioactivation of clozapine by murine cardiac tissue in vivo and in vitro.

Dominic P. Williams, M. Pirmohamed, B. K. Park, 2003, Chemical research in toxicology.

Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of alpha-hydroxytamoxifen in vitro: a metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts.

I. White, B. K. Park, J. Maggs, 2000, Carcinogenesis.

Synthesis, antimalarial activity, and preclinical pharmacology of a novel series of 4'-fluoro and 4'-chloro analogues of amodiaquine. Identification of a suitable "back-up" compound for N-tert-butyl isoquine.

S. Parapini, D. Taramelli, C. Davis, 2009, Journal of medicinal chemistry.

Structural basis for the haemotoxicity of dapsone: the importance of the sulphonyl group.

J. Dearden, M. Cronin, B. K. Park, 1997, Toxicology.

In vitro metabolism of dexamethasone (DEX) in human liver and kidney: the involvement of CYP3A4 and CYP17 (17,20 LYASE) and molecular modelling studies.

D. Lewis, H. Kroemer, B. K. Park, 1997, Biochemical pharmacology.

Cortisol metabolism by human liver in vitro—IV. Metabolism of 9α-fluorocortisol by human liver microsomes and cytosol

B. K. Park, D. Back, J. Maggs, 1993, The Journal of Steroid Biochemistry and Molecular Biology.

Haloarene derivatives of carbamazepine with reduced bioactivation liabilities: 2-monohalo and 2,8-dihalo derivatives.

Dominic P. Williams, B. K. Park, L. Parry, 2012, Journal of medicinal chemistry.

P29The metabolism of carbamazepine in fresh rodent hepatocyte suspensions: The effect of bromine substitution on metabolism

Dominic P. Williams, J. Maggs, Kevin B. Park, 2010 .

Drug-protein conjugates--VIII. The metabolic fate of the dinitrophenyl hapten conjugated to albumin.

N. Kitteringham, B. K. Park, J. Maggs, 1985, Biochemical pharmacology.

Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans.

J. Ashby, B. K. Park, J. Maggs, 2001, The Journal of pharmacology and experimental therapeutics.

Optimal dose identification: predicting a safe dose in man from animal studies

M. Pirmohamed, I. White, N. Kitteringham, 2001 .

Novel, potent, semisynthetic antimalarial carba analogues of the first-generation 1,2,4-trioxane artemether.

B. K. Park, S. Ward, P. O’Neill, 1999, Journal of medicinal chemistry.

Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of benzylamino and alkylamino ether analogues of artemisinin.

B. K. Park, S. Ward, P. O’Neill, 1996, Journal of medicinal chemistry.

A mechanistic investigation into the irreversible protein binding and antigenicity of p-phenylenediamine.

N. Kitteringham, B. K. Park, D. Naisbitt, 2009, Chemical research in toxicology.

Multiple adduction reactions of nitroso sulfamethoxazole with cysteinyl residues of peptides and proteins: implications for hapten formation.

B. K. Park, D. Naisbitt, R. Jenkins, 2009, Chemical research in toxicology.

Auto-oxidation of Isoniazid Leads to Isonicotinic-Lysine Adducts on Human Serum Albumin.

B. K. Park, D. Naisbitt, J. Maggs, 2015, Chemical research in toxicology.

The biliary and urinary metabolites of [3H]17 alpha-ethynylestradiol in women.

A. Breckenridge, B. K. Park, J. Maggs, 1983, Xenobiotica; the fate of foreign compounds in biological systems.

Covalent adduction of carbamazepine 10, 11-epoxide with human serum albumin and glutathione S-transferase pi: implications for carbamazepine hypersensitivity

M. Pirmohamed, A. Marson, J. Maggs, 2014, The Lancet.

The effect of chemical substitution on the metabolic activation, metabolic detoxication, and pharmacological activity of amodiaquine in the mouse.

B. K. Park, S. Ward, P. O’Neill, 1995, The Journal of pharmacology and experimental therapeutics.

Characterisation of the NRF2 transcriptional network and its response to chemical insult in primary human hepatocytes: implications for prediction of drug-induced liver injury

Yongxiang Fang, L. Rainbow, J. Sutherland, 2018, Archives of Toxicology.

The enterohepatic circulation of the metabolites of 17α-ethynyl[3H]estradiol in the rat

J. Maggs, P. Grabowski, B. Park, 1983 .

Drug-protein conjugates--X. The role of protein conjugation in the disposition of dinitrofluorobenzene.

N. Kitteringham, J. Maggs, P. Grabowski, 1986, Biochemical pharmacology.

A comparative study of biliary and urinary 2-hydroxylated metabolites of [6,7-3H]17 alpha-ethynylestradiol in women.

J. Maggs, B. Park, 1985, Contraception.

Drug protein conjugates--III. Inhibition of the irreversible binding of ethinylestradiol to rat liver microsomal protein by mixed-function oxidase inhibitors, ascorbic acid and thiols.

J. Maggs, P. Grabowski, B. Park, 1983, Journal of steroid biochemistry.

Identification of the Thiophene Ring of Methapyrilene as a Novel Bioactivation-Dependent Hepatic Toxicophore

Dominic P. Williams, I. Wilson, J. Maggs, 2008, Journal of Pharmacology and Experimental Therapeutics.

Oxidative bioactivation of abacavir in subcellular fractions of human antigen presenting cells.

D. Naisbitt, P. O’Neill, J. Maggs, 2013, Chemical research in toxicology.

Novel, potent, semisynthetic antimalarial carba analogues of the first-generation 1,2,4-trioxane artemether.

S. Ward, P. O’Neill, J. Maggs, 1999, Journal of medicinal chemistry.

Dapsone and Nitroso Dapsone Activation of Naı̈ve T-Cells from Healthy Donors.

D. Naisbitt, M. Ogese, J. Maggs, 2017, Chemical research in toxicology.